4.7 Article

Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Cdk1 Participates in BRCA1-Dependent S Phase Checkpoint Control in Response to DNA Damage

Neil Johnson et al.

MOLECULAR CELL (2009)

Article Cell Biology

p21 inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint

Ande Satyanarayana et al.

MOLECULAR BIOLOGY OF THE CELL (2008)

Article Multidisciplinary Sciences

Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1

Shaoyong Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Chemistry, Medicinal

3-aminopyrazole inhibitors of CDK2/cyclin a as antitumor agents. 2. Lead optimization

P Pevarello et al.

JOURNAL OF MEDICINAL CHEMISTRY (2005)

Article Oncology

Cdk inhibitor p27(Kip1) and hormone dependence in breast cancer

CL Arteaga

CLINICAL CANCER RESEARCH (2004)

Article Biochemistry & Molecular Biology

Cdk2 knockout mice are viable

C Berthet et al.

CURRENT BIOLOGY (2003)

Article Oncology

Proliferation of cancer cells despite CDK2 inhibition

O Tetsu et al.

CANCER CELL (2003)

Article Biochemistry & Molecular Biology

Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor

TG Davies et al.

NATURE STRUCTURAL BIOLOGY (2002)

Article Biochemistry & Molecular Biology

E2F activity is biphasically regulated by androgens in LNCaP cells

K Hofman et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)

Article Multidisciplinary Sciences

Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells

S Cariou et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)